"The chemotherapeutic agent DMXAA is a unique IRF3-dependent type-2 vaccine adjuvant." has been accepted for publication in PLOS ONE. (2013-2-26)

The chemotherapeutic agent DMXAA is a unique IRF3-dependent type-2 vaccine adjuvant.

Choon Kit Tang, Taiki Aoshi, Nao Jounai, Junichi Ito, Keiichi Ohata, Kouji Kobiyama, Benoit H Dessailly, Etsushi Kuroda, Shizuo Akira, Kenji Mizuguchi, Cevayir Coban and Ken J Ishii.
PLOS ONE.

We will give you the details later.

2013-02-26 | カテゴリー : Research | 投稿者 : bioinfoadmin